<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04996290</url>
  </required_header>
  <id_info>
    <org_study_id>B3002020000032</org_study_id>
    <nct_id>NCT04996290</nct_id>
  </id_info>
  <brief_title>Combined PENG and LFCN Block for Total Hip Arthroplasty</brief_title>
  <official_title>Combined Pericapsular Nerve Group (PENG) and Lateral Femoral Cutaneous Nerve (LFCN) Block for Total Hip Arthroplasty: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A clinical trial investigating the effect of a combined locoregional anesthesia technique on&#xD;
      the postoperative analgesia outcomes after a total hip arthroplasty. A PENG block will be&#xD;
      used in combination with a LFCN block. The results will be compared to a control group that&#xD;
      is solely treated with intravenous analgesia. This technique aims to provide improved pain&#xD;
      scores after surgery without interference of revalidation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Actual">October 1, 2020</completion_date>
  <primary_completion_date type="Actual">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Initial pain score</measure>
    <time_frame>0 hours postoperative</time_frame>
    <description>numeric rating score (NRS) of 0 to 10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score after 2h</measure>
    <time_frame>2 hours postoperative</time_frame>
    <description>numeric rating score (NRS) of 0 to 10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score after 24h</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>numeric rating score (NRS) of 0 to 10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Initial motor function</measure>
    <time_frame>0 hours postoperative</time_frame>
    <description>score chart inspired by the Bromage score (NRS) of 0 to 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor function after 2h</measure>
    <time_frame>2 hours postoperative</time_frame>
    <description>score chart inspired by the Bromage score (NRS) of 0 to 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor function after 24h</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>score chart inspired by the Bromage score (NRS) of 0 to 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative opioids</measure>
    <time_frame>intraoperative</time_frame>
    <description>dose of intravenous opioids in microgram per kilogram bodyweight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative opioids</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>dose of intravenous opioids in microgram per kilogram bodyweight</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Anesthesia, Conduction</condition>
  <condition>Pain, Postoperative</condition>
  <condition>Arthroplasty, Replacement, Hip</condition>
  <arm_group>
    <arm_group_label>PENG + LFCN block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants in this group received a combined regional technique just before surgery:&#xD;
Pericapsular nerve group (PENG) block&#xD;
Lateral femoral cutaneus nerve (LFCN) block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No regional anesthesia</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PENG + LFCN block</intervention_name>
    <description>Regional anesthesia technique</description>
    <arm_group_label>PENG + LFCN block</arm_group_label>
    <other_name>pericapsular nerve group block</other_name>
    <other_name>lateral femoral cutaneous nerve block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine injection</intervention_name>
    <description>Local anesthetic used for peripheral nerve block.</description>
    <arm_group_label>PENG + LFCN block</arm_group_label>
    <other_name>ropivacaine 0.375%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients who underwent a primary total hip replacement under general anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  insulin dependent diabetes mellitus&#xD;
&#xD;
          -  chronic pain&#xD;
&#xD;
          -  severe dementia or mental retardation&#xD;
&#xD;
          -  allergy to local anesthetics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yzabel Vandevivere, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AZ Monica</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AZ Monica</name>
      <address>
        <city>Deurne</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Girón-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.</citation>
    <PMID>30063657</PMID>
  </reference>
  <reference>
    <citation>Morrison C, Brown B, Lin DY, Jaarsma R, Kroon H. Analgesia and anesthesia using the pericapsular nerve group block in hip surgery and hip fracture: a scoping review. Reg Anesth Pain Med. 2021 Feb;46(2):169-175. doi: 10.1136/rapm-2020-101826. Epub 2020 Oct 27. Review.</citation>
    <PMID>33109730</PMID>
  </reference>
  <reference>
    <citation>Wainwright TW, Gill M, McDonald DA, Middleton RG, Reed M, Sahota O, Yates P, Ljungqvist O. Consensus statement for perioperative care in total hip replacement and total knee replacement surgery: Enhanced Recovery After Surgery (ERAS(®)) Society recommendations. Acta Orthop. 2020 Feb;91(1):3-19. doi: 10.1080/17453674.2019.1683790. Epub 2019 Oct 30. Review. Update in: Acta Orthop. 2020 Feb 14;:1.</citation>
    <PMID>31663402</PMID>
  </reference>
  <reference>
    <citation>Roy R, Agarwal G, Pradhan C, Kuanar D. Total postoperative analgesia for hip surgeries, PENG block with LFCN block. Reg Anesth Pain Med. 2019 Mar 28. pii: rapm-2019-100454. doi: 10.1136/rapm-2019-100454. [Epub ahead of print]</citation>
    <PMID>30923252</PMID>
  </reference>
  <reference>
    <citation>Højer Karlsen AP, Geisler A, Petersen PL, Mathiesen O, Dahl JB. Postoperative pain treatment after total hip arthroplasty: a systematic review. Pain. 2015 Jan;156(1):8-30. doi: 10.1016/j.pain.0000000000000003. Review.</citation>
    <PMID>25599296</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 19, 2021</study_first_submitted>
  <study_first_submitted_qc>August 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Antwerp</investigator_affiliation>
    <investigator_full_name>Lennert De Schrijver</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>regional anesthesia</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>total hip arthroplasty</keyword>
  <keyword>pericapsular nerve group block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

